Sabre Insurance Group plc

LSE:SBRE Stock Report

Market Cap: UK£330.4m

Sabre Insurance Group Valuation

Is SBRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SBRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SBRE (£1.33) is trading below our estimate of fair value (£1.52)

Significantly Below Fair Value: SBRE is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SBRE?

Key metric: As SBRE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SBRE. This is calculated by dividing SBRE's market cap by their current earnings.
What is SBRE's PE Ratio?
PE Ratio11.3x
EarningsUK£29.35m
Market CapUK£330.38m

Price to Earnings Ratio vs Peers

How does SBRE's PE Ratio compare to its peers?

The above table shows the PE ratio for SBRE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average7.9x
LRE Lancashire Holdings
5x-7.2%UK£1.5b
DLG Direct Line Insurance Group
6.8x8.0%UK£2.1b
HSX Hiscox
6.2x-2.4%UK£3.5b
PGH Personal Group Holdings
13.8x18.7%UK£62.6m
SBRE Sabre Insurance Group
11.3x13.7%UK£330.4m

Price-To-Earnings vs Peers: SBRE is expensive based on its Price-To-Earnings Ratio (11.3x) compared to the peer average (7.9x).

Price to Earnings Ratio vs Industry

How does SBRE's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
SBRE 11.3xIndustry Avg. 11.8xNo. of Companies12PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SBRE is good value based on its Price-To-Earnings Ratio (11.3x) compared to the European Insurance industry average (11.5x).

Price to Earnings Ratio vs Fair Ratio

What is SBRE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SBRE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.3x
Fair PE Ratio13.4x

Price-To-Earnings vs Fair Ratio: SBRE is good value based on its Price-To-Earnings Ratio (11.3x) compared to the estimated Fair Price-To-Earnings Ratio (13.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SBRE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£1.33
UK£1.88
+41.4%
11.5%UK£2.16UK£1.40n/a8
Nov ’25UK£1.37
UK£1.91
+39.8%
8.0%UK£2.16UK£1.65n/a8
Oct ’25UK£1.40
UK£2.00
+42.5%
9.1%UK£2.20UK£1.65n/a8
Sep ’25UK£1.56
UK£1.99
+27.8%
9.2%UK£2.20UK£1.65n/a8
Aug ’25UK£1.59
UK£1.99
+25.0%
9.0%UK£2.20UK£1.65n/a8
Jul ’25UK£1.50
UK£1.98
+32.4%
9.0%UK£2.20UK£1.65n/a8
Jun ’25UK£1.69
UK£1.98
+17.5%
9.0%UK£2.20UK£1.65n/a8
May ’25UK£1.60
UK£1.91
+19.9%
11.6%UK£2.20UK£1.45n/a8
Apr ’25UK£1.79
UK£1.85
+3.2%
12.5%UK£2.20UK£1.45n/a8
Mar ’25UK£1.59
UK£1.81
+13.5%
10.1%UK£2.00UK£1.45n/a8
Feb ’25UK£1.55
UK£1.69
+8.8%
7.6%UK£1.81UK£1.45n/a6
Jan ’25UK£1.51
UK£1.66
+9.5%
12.0%UK£1.81UK£1.20n/a7
Dec ’24UK£1.42
UK£1.64
+15.5%
12.5%UK£1.81UK£1.20n/a7
Nov ’24UK£1.47
UK£1.63
+10.9%
12.1%UK£1.81UK£1.20UK£1.377
Oct ’24UK£1.51
UK£1.63
+7.5%
15.8%UK£2.10UK£1.20UK£1.407
Sep ’24UK£1.54
UK£1.62
+5.7%
15.9%UK£2.10UK£1.20UK£1.567
Aug ’24UK£1.40
UK£1.52
+8.8%
16.8%UK£2.10UK£1.20UK£1.598
Jul ’24UK£1.35
UK£1.51
+11.2%
17.2%UK£2.10UK£1.20UK£1.508
Jun ’24UK£1.40
UK£1.51
+7.3%
17.2%UK£2.10UK£1.20UK£1.698
May ’24UK£1.26
UK£1.44
+13.6%
23.8%UK£2.10UK£0.93UK£1.607
Apr ’24UK£1.13
UK£1.41
+25.2%
24.8%UK£2.10UK£0.93UK£1.797
Mar ’24UK£0.99
UK£1.47
+48.1%
21.1%UK£2.10UK£1.12UK£1.598
Feb ’24UK£0.98
UK£1.47
+49.0%
21.1%UK£2.10UK£1.12UK£1.558
Jan ’24UK£1.06
UK£1.48
+39.2%
19.8%UK£2.10UK£1.19UK£1.518
Dec ’23UK£1.03
UK£1.48
+43.8%
19.8%UK£2.10UK£1.19UK£1.428
Nov ’23UK£0.89
UK£1.43
+60.2%
21.5%UK£2.10UK£1.05UK£1.479

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Lancashire Holdings

UK£1.5b

Provides specialty insurance and reinsurance products in London, Bermuda, and Australia.

LREL

UK£6.05

7D

-10.6%

1Y

-4.4%

Swiss Re

CHF 28.1b

Provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide.

SRENZ

CHF 96.62

7D

2.0%

1Y

4.1%

FBD Holdings

€523.9m

Through its subsidiaries, engages in the underwriting of general insurance to farmers, private individuals, and business owners in Ireland.

FBH

€13.15

7D

0%

1Y

1.5%